ReportGem ReportGem

GLOBAL RESEARCH ARCHIVE

CBD 2Q26 - Mixed Results. Sales Declined, But Profitability Was Again the Highlight

Published: 2026-08-05Institution: JPMorganCompany / ticker: PCAR3.SAPages: 8Original language: 英语
PCAR3.SA coverageJPMorgan research

Research evidence excerpt

The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.

The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.

Open report viewer

Related research and intelligence

Companhia Brasileira de Distribuicao: 2Q26 Earnings: Debt Recovery Plan Progress Amid Deteriorating SSS2026-08-05 · Morgan StanleyCBD 2Q26 Conference Call Highlights2026-08-05 · JPMorganSmartStop Good Expense Trends Help Drive 2Q FFO Upside and Guidance Increase2026-08-05 · JPMorganCushman & Wakefield 2Q Top Line/EBITDA Beat, Guidance Raised; Strong Leasing Offset Particularly Weak Capital Markets2026-08-05 · JPMorganUnicharm (8113) 2Q results: Watching specific measures on price pass-through and likelihood from 3Q onward2026-08-05 · JPMorganOil and Natural Gas Corporation 1Q: In-line EBITDA driven by higher oil prices; volumes weak2026-08-05 · JPMorgan